AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

COLLEGIUM PHARMACEUTICAL, INC Director's Dealing 2018

Mar 26, 2018

32163_dirs_2018-03-26_1c137ef1-4c78-4bb3-98e6-6436d1036e2c.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-03-16

Reporting Person: Kuhlmann Shirley R. (EVP and General Counsel)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities beneficially owned	0	Direct